Cannabis: WHO just acknowledged historical misjudgment and heads towards global policy update

After thoroughly assessing Cannabis, THC and CBD in June, the WHO has just recognized its historical misjudgment that led to the placement of Cannabis medicines among heroin or fentanyl derivates, and will consider an international change of scheduling to adequate policies with evidence. #ECDD40

Communiqué de presse: Cannabis & OMS – 40ème Comité d’Experts ECDD

COMMUNIQUÉ. Politiques du Cannabis : des Activistes de tous les continents se concentrent à Genève – Journée historique à l’Organisation Mondiale de la Santé.

Human Rights violations in the name of Drug Control: contribution to UN Human Rights

57 years of Global and Systematic Human Rights violations in the name of #DrugControl: Right to a Remedy and Reparation for Victims of Gross Violations of International Human Rights Law.

[VIDEO] L’hépatite C parmi les usager.e.s de drogues, les gouvernements & l’ONU.

Dans l’enceinte de l’ONU en mars dernier, FAAAT a pris part à la mise en place d’une conférence de consensus où gouvernements et société civile on pu dresser un bilan mondial de l’action publique relative au VHC, et discutter des recommendations issues du terrain. Vidéo et compte-rendu.

Cannabis review by the WHO: all you need to know

In 2018 for the first time, the World Health Organization is assessing the medical uses and harms of Cannabis, and will recommend the suitable classification to be applied internationally. We promote an objective and independent assessment, that recognizes and acknowledges modern research on Cannabis. Support us!

Will modern drug policies come from Norway?

The Norwegian Association for Safer Drug Policies, FAAAT and 20 policymakers and stakeholders from 10 countries recalled that Norway should be a model for the rest of the world’s drug policy reforms.

Pin It on Pinterest